These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32072842)

  • 21. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
    Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
    J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuing challenges in the management of retinoblastoma with chemotherapy.
    Shields CL; Meadows AT; Leahey AM; Shields JA
    Retina; 2004 Dec; 24(6):849-62. PubMed ID: 15579981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
    Berry JL; Jubran R; Kim JW; Wong K; Bababeygy SR; Almarzouki H; Lee TC; Murphree AL
    Pediatr Blood Cancer; 2013 Apr; 60(4):688-93. PubMed ID: 22997170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
    Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome.
    Russo I; Levy-Gabriel C; Dupont A; Lumbroso-Le Rouic L; Cassoux N; Desjardins L; Bertozzi AI; Coze C; Doz F; Savignoni A; Aerts I
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28721. PubMed ID: 33098751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors.
    Shields CL; Shields JA; Cater J; Othmane I; Singh AD; Micaily B
    Ophthalmology; 2001 Nov; 108(11):2116-21. PubMed ID: 11713089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External beam radiotherapy in retinoblastoma: tumor control and comparison of 2 techniques.
    Scott IU; Murray TG; Feuer WJ; Van Quill K; Markoe AM; Ling S; Roth DB; O'Brien JM
    Arch Ophthalmol; 1999 Jun; 117(6):766-70. PubMed ID: 10369587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.
    Shields CL; Bas Z; Tadepalli S; Dalvin LA; Rao R; Schwendeman R; Lally SE; Shields JA; Shah A; Leahey A
    Br J Ophthalmol; 2020 Nov; 104(11):1548-1555. PubMed ID: 32051141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma.
    Brennan RC; Qaddoumi I; Mao S; Wu J; Billups CA; Stewart CF; Hoehn ME; Rodriguez-Galindo C; Wilson MW
    J Clin Oncol; 2017 Jan; 35(1):72-77. PubMed ID: 28034080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
    Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
    Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoreduction followed by local therapy and adjuvant chemotherapy for advanced intraocular retinoblastoma: a pilot study in a single center.
    Yoo KH; Sohn WY; Sung KW; Jung HL; Koo HH; Oh SY; Kang SW
    J Korean Med Sci; 2002 Dec; 17(6):817-22. PubMed ID: 12483008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The modern role of radiation therapy in treating advanced-stage retinoblastoma: long-term outcomes and racial differences.
    Orman A; Koru-Sengul T; Miao F; Markoe A; Panoff JE
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1037-43. PubMed ID: 25442037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periocular topotecan for vitreous seeds in retinoblastoma.
    Sthapit PR; Rao R; Honavar SG
    Indian J Ophthalmol; 2018 Dec; 66(12):1833-1838. PubMed ID: 30451190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical approach to management of retinoblastoma.
    Shields CL; Mashayekhi A; Demirci H; Meadows AT; Shields JA
    Arch Ophthalmol; 2004 May; 122(5):729-35. PubMed ID: 15136321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
    Berry JL; Shah S; Bechtold M; Zolfaghari E; Jubran R; Kim JW
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.